• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞-巨噬细胞相互作用在肝纤维化和癌变中的作用。

Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

机构信息

Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.

出版信息

Semin Liver Dis. 2020 Aug;40(3):307-320. doi: 10.1055/s-0040-1708876. Epub 2020 Apr 2.

DOI:10.1055/s-0040-1708876
PMID:32242330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7484001/
Abstract

Chronic liver injury due to viral hepatitis, alcohol abuse, and metabolic disorders is a worldwide health concern. Insufficient treatment of chronic liver injury leads to fibrosis, causing liver dysfunction and carcinogenesis. Most cases of hepatocellular carcinoma (HCC) develop in the fibrotic liver. Pathological features of liver fibrosis include extracellular matrix (ECM) accumulation, mesenchymal cell activation, immune deregulation, and angiogenesis, all of which contribute to the precancerous environment, supporting tumor development. Among liver cells, hepatic stellate cells (HSCs) and macrophages play critical roles in fibrosis and HCC. These two cell types interplay and remodel the ECM and immune microenvironment in the fibrotic liver. Once HCC develops, HCC-derived factors influence HSCs and macrophages to switch to protumorigenic cell populations, cancer-associated fibroblasts and tumor-associated macrophages, respectively. This review aims to summarize currently available data on the roles of HSCs and macrophages in liver fibrosis and HCC, with a focus on their interaction.

摘要

慢性肝损伤由病毒性肝炎、酗酒和代谢紊乱引起,是一个全球性的健康问题。慢性肝损伤治疗不充分可导致纤维化,导致肝功能障碍和癌变。大多数肝细胞癌(HCC)发生在纤维化的肝脏中。肝纤维化的病理特征包括细胞外基质(ECM)积累、间充质细胞激活、免疫失调和血管生成,所有这些都有助于癌前环境,支持肿瘤的发展。在肝细胞中,肝星状细胞(HSCs)和巨噬细胞在纤维化和 HCC 中起着关键作用。这两种细胞类型相互作用,重塑纤维化肝脏中的 ECM 和免疫微环境。一旦 HCC 发生,HCC 衍生的因子影响 HSCs 和巨噬细胞分别向促肿瘤细胞群(即癌症相关成纤维细胞和肿瘤相关巨噬细胞)转化。本综述旨在总结目前关于 HSCs 和巨噬细胞在肝纤维化和 HCC 中的作用的相关数据,重点关注它们的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a16/7484001/f6ccf987bbdc/nihms-1590380-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a16/7484001/ddec4785617a/nihms-1590380-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a16/7484001/f6ccf987bbdc/nihms-1590380-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a16/7484001/ddec4785617a/nihms-1590380-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a16/7484001/f6ccf987bbdc/nihms-1590380-f0002.jpg

相似文献

1
Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.肝星状细胞-巨噬细胞相互作用在肝纤维化和癌变中的作用。
Semin Liver Dis. 2020 Aug;40(3):307-320. doi: 10.1055/s-0040-1708876. Epub 2020 Apr 2.
2
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.纤维化和肝相关成纤维细胞在肝细胞癌发病机制中的作用。
Int J Mol Sci. 2019 Apr 7;20(7):1723. doi: 10.3390/ijms20071723.
3
Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.肝细胞癌中的肝星状细胞与细胞外基质:比以往任何时候都更复杂。
Liver Int. 2014 Jul;34(6):834-43. doi: 10.1111/liv.12465. Epub 2014 Feb 12.
4
Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma.肝星状细胞调节肝癌进展中的免疫微环境。
Int J Mol Sci. 2022 Sep 15;23(18):10777. doi: 10.3390/ijms231810777.
5
Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.肝星状细胞与单核细胞相互作用导致肝细胞癌预后不良。
Hepatology. 2015 Aug;62(2):481-95. doi: 10.1002/hep.27822. Epub 2015 Apr 28.
6
Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.肝细胞癌细胞及其纤维化微环境调节骨髓间充质基质细胞在体外和体内的迁移。
Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19.
7
Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.在斑马鱼中,肝星状细胞在肝癌发生过程中的激活需要纤维蛋白原/整合素αvβ5。
Neoplasia. 2018 May;20(5):533-542. doi: 10.1016/j.neo.2018.02.002. Epub 2018 Apr 9.
8
Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver.解析肿瘤微环境中肝星状细胞与癌细胞之间可能存在的相互循环。
Crit Rev Oncol Hematol. 2023 Feb;182:103902. doi: 10.1016/j.critrevonc.2022.103902. Epub 2023 Jan 5.
9
Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions.受损肝脏窦周间隙中肝细胞间的通讯:病理生理学与治疗方向。
J Cell Physiol. 2023 Jan;238(1):70-81. doi: 10.1002/jcp.30915. Epub 2022 Nov 21.
10
IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.脂肪变性肝细胞和巨噬细胞中的 IL-17 信号转导促进酒精性肝病中的肝细胞癌。
J Hepatol. 2020 May;72(5):946-959. doi: 10.1016/j.jhep.2019.12.016. Epub 2019 Dec 31.

引用本文的文献

1
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
2
Extracellular vesicles: emerging therapeutic agents for liver fibrosis.细胞外囊泡:肝脏纤维化的新兴治疗药物
Extracell Vesicles Circ Nucl Acids. 2025 May 7;6(2):216-244. doi: 10.20517/evcna.2025.08. eCollection 2025.
3
Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice.

本文引用的文献

1
Collagen Density Modulates the Immunosuppressive Functions of Macrophages.胶原蛋白密度调节巨噬细胞的免疫抑制功能。
J Immunol. 2020 Sep 1;205(5):1461-1472. doi: 10.4049/jimmunol.1900789. Epub 2020 Jul 27.
2
Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma.活化的肝星状细胞通过 SDF-1/CXCR4 轴调节 MDSC 在肝癌原位小鼠模型中的迁移。
Cancer Immunol Immunother. 2019 Dec;68(12):1959-1969. doi: 10.1007/s00262-019-02414-9. Epub 2019 Oct 23.
3
Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling.
无论小鼠是否存在内皮功能障碍,培马贝特均可改善脂肪性肝病。
Antioxidants (Basel). 2025 Jul 20;14(7):891. doi: 10.3390/antiox14070891.
4
Myeloid cells in chronic liver inflammation.慢性肝脏炎症中的髓样细胞。
Cell Mol Immunol. 2025 Jul 28. doi: 10.1038/s41423-025-01324-4.
5
Non-targeted metabolomics and network pharmacology of Taohong Siwu Decoction in hepatic fibrosis mouse model using high resolution mass spectrometry.基于高分辨率质谱法对肝纤维化小鼠模型中桃红四物汤进行非靶向代谢组学及网络药理学研究
Front Mol Biosci. 2025 Jun 30;12:1614341. doi: 10.3389/fmolb.2025.1614341. eCollection 2025.
6
Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases.细菌细胞外囊泡:肝病中肠-肝轴相互作用的新兴介质
Front Cell Infect Microbiol. 2025 Jun 20;15:1620829. doi: 10.3389/fcimb.2025.1620829. eCollection 2025.
7
Integrated Lipidomics and Network Pharmacology to Reveal the Mechanisms of Franch in the Treatment of Liver Fibrosis in Mice.整合脂质组学与网络药理学揭示Franch对小鼠肝纤维化的治疗机制
ACS Omega. 2025 Jun 20;10(25):26765-26775. doi: 10.1021/acsomega.5c01398. eCollection 2025 Jul 1.
8
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights.基于纳米颗粒的慢性肝病治疗策略:进展与见解
Liver Res. 2025 Apr 12;9(2):104-117. doi: 10.1016/j.livres.2025.04.002. eCollection 2025 Jun.
9
Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities.解读肝纤维化-肝细胞癌轴:从机制到治疗机遇
Hepatol Int. 2025 Jul 1. doi: 10.1007/s12072-025-10838-y.
10
Bridging Immune Evasion and Vascular Dynamics for Novel Therapeutic Frontiers in Hepatocellular Carcinoma.肝细胞癌新型治疗前沿:连接免疫逃逸与血管动力学
Cancers (Basel). 2025 May 31;17(11):1860. doi: 10.3390/cancers17111860.
肝星状细胞通过白细胞介素 6 信号诱导髓源性抑制细胞增强肝癌进展。
Int J Mol Sci. 2019 Oct 13;20(20):5079. doi: 10.3390/ijms20205079.
4
Resolving the fibrotic niche of human liver cirrhosis at single-cell level.解析人肝硬化的纤维性龛位于单细胞水平。
Nature. 2019 Nov;575(7783):512-518. doi: 10.1038/s41586-019-1631-3. Epub 2019 Oct 9.
5
Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.透明质酸合酶 2 介导的透明质酸生成介导 Notch1 激活和肝纤维化。
Sci Transl Med. 2019 Jun 12;11(496). doi: 10.1126/scitranslmed.aat9284.
6
Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis.4-甲基伞形酮抑制透明质酸合成可降低肝癌发生过程中肿瘤干细胞标志物的表达。
Sci Rep. 2019 Mar 11;9(1):4026. doi: 10.1038/s41598-019-40436-6.
7
The Role of Angiogenesis in Hepatocellular Carcinoma.血管生成在肝细胞癌中的作用。
Clin Cancer Res. 2019 Feb 1;25(3):912-920. doi: 10.1158/1078-0432.CCR-18-1254. Epub 2018 Oct 1.
8
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
9
The innate immune receptor TREM-1 promotes liver injury and fibrosis.天然免疫受体 TREM-1 促进肝损伤和纤维化。
J Clin Invest. 2018 Nov 1;128(11):4870-4883. doi: 10.1172/JCI98156. Epub 2018 Oct 2.
10
The role of Kupffer cells in hepatic iron and lipid metabolism.库普弗细胞在肝脏铁和脂质代谢中的作用。
J Hepatol. 2018 Nov;69(5):1197-1199. doi: 10.1016/j.jhep.2018.02.013. Epub 2018 Jul 9.